Prevalence of nonsuppressed viral load and associated factors among HIV‐positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population‐based nationally representative surveys

A. Haas,E. Radin,Avi J. Hakim,A. Jahn,N. Philip,Sasi Jonnalagadda,S. Saito,A. Low,Hetal K Patel,Amee M. Schwitters,J. Rogers,K. Frederix,Evelyn Kim,G. Bello,Daniel B Williams,B. Parekh,Karampreet Sachathep,D. Barradas,T. Kalua,S. Birhanu,G. Musuka,O. Mugurungi,B. T. Tippett Barr,K. Sleeman,L. Mulenga,Kyaw Thin,T. Ao,Kristin Brown,A. Voetsch,J. Justman

Published 2020 in Journal of the International AIDS Society

ABSTRACT

The global target for 2020 is that ≥90% of people living with HIV (PLHIV) receiving antiretroviral therapy (ART) will achieve viral load suppression (VLS). We examined VLS and its determinants among adults receiving ART for at least four months.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-44 of 44 references · Page 1 of 1

CITED BY

Showing 1-47 of 47 citing papers · Page 1 of 1